We know disease exists, where it comes from and how it evolves - but we don’t yet know ahead of time when something changes to mark the start of a new disease, a new variant or just an increase in transmission.
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance.
David Leitham, senior vice president and general manager at software company AspenTech looks at why process analytical technology (PAT) is essential for the journey to Pharma 4.0.
Ray Chohan co-founder and vice president of new ventures at innovation intelligence expert Patsnap looks at technology’s ability to expedite the analysis of data in pharma and how it can help bring about new therapies for patients.
EPM speaks to Nigel Skinner, Marketing Director at Andrew Alliance about how automation is being used throughout the pharma industry and how it is helping bring new drugs to market faster.
Damiano Rossi, head of Applications – Particle Engineering and Microfluidics, Dolomite Microfluidics looks at how computational fluid dynamics modelling and AI are helping scientists predict the outcomes of microfluidic experiments.
Richard Porter, pharmaceutical director at AspenTech looks at how automated technologies are helping pharma companies transform their manufacturing processes.
Igor Kruglyak, senior advisor at the global IT service provider Avenga and Michael DePalma, founder and president of digital specialists Pensare, LLC, examine the use of natural language processing (NLP) for investigator recruitment acceleration.
